Live Breaking News & Updates on Incannex healthcare inc

Stay informed with the latest breaking news from Incannex healthcare inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Incannex healthcare inc and stay connected to the pulse of your community

Short Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Expands By 113.1%

Short Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Expands By 113.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Advisorshares-investments , Nasdaq , Mirae-asset-global-investments-co , Citadel-advisors , Incannex-healthcare-inc , Incannex-healthcare , Get-free-report , Street-group , Shares-investments , Mirae-asset-global-investments , Healthcare-inc

11 Best ASX Stocks To Buy Now

In this piece, we will take a look at the 11 best ASX stocks to buy now. If you want to skip our introduction to the Australian stock market, then you can take a look at the 5 Best ASX Stocks To Buy Now. With a market capitalization of $1.5 trillion, the Australian stock exchange, […]

Israel , Melbourne , Victoria , Australia , Sydney , New-south-wales , Aaron-cowen-suvretta , Robertmp-luciano , Deswarte-shutterstock , Immutep-limited , Nasdaq , Opthea-limited

Incannex Announces Positive Topline Results from Phase 2

Highlights: PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of 12.8...

Melbourne , Victoria , Australia , Monash , South-australia , United-states , Joel-latham , Paul-liknaitzky , Laine-yonker , Nasdaq , Edison-group , Clinical-psychedelic-lab-at-monash-university

Incannex's Phase 2 Psi-GAD1 Trial Of Psilocybin Meets Primary Endpoint; Stock Surges 39%

Biotechnology company, Incannex Healthcare Inc. (IXHL), Wednesday announced positive results from its Phase 2 Psi-GAD1 clinical trial of psilocybin for the treatment of generalized anxiety disorder or GAD.

Paul-liknaitzky , Nasdaq , Clinical-psychedelic-lab-at-monash-university , Incannex-healthcare-inc , Incannex-healthcare , Clinical-psychedelic-lab , Monash-university ,

What's Going On With Incannex Stock? - Incannex Healthcare (NASDAQ:IXHL)

Incannex said that its Phase 2 Psi-GAD1 clinical trial of psilocybin in generalized anxiety disorder met its primary endpoint of demonstrating a large clinical effect in the psilocybin treatment group over the placebo group.

United-states , United-kingdom , Joel-latham , Incannex-healthcare-inc , Clerkenwell-health ,

Incannex Stock Surges 45% On Psilocybin Study Results

Shares of Incannex Healthcare Inc. (IXHL) surged over 45% on Wednesday after the biotechnology company announced positive results from its mid-stage Psi-GAD1 clinical trial of psilocybin for the treatment of generalized anxiety disorder or GAD.

Nasdaq , Drug-administration , Incannex-healthcare-inc , Incannex-healthcare , Investigational-new-drug , Incannex ,